BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11008709)

  • 1. [Relationship between rhodamine 6G accumulation and fluconazole resistance in Saccharomyces cerevisiae S288c].
    Stella CA; Burgos HI; Costanzo R
    Rev Argent Microbiol; 2000; 32(3):157-60. PubMed ID: 11008709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-proline as a nitrogen source increases the susceptibility of Saccharomyces cerevisiae S288c to fluconazole.
    Stella CA; Costanzo R; Burgos HI; Saenz DA; Venerus RD
    Folia Microbiol (Praha); 1998; 43(4):403-5. PubMed ID: 9821294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efflux-mediated resistance to fluconazole could be modulated by sterol homeostasis in Saccharomyces cerevisiae.
    Kontoyiannis DP
    J Antimicrob Chemother; 2000 Aug; 46(2):199-203. PubMed ID: 10933641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces cerevisiae.
    Kontoyiannis DP
    J Antimicrob Chemother; 2000 Aug; 46(2):191-7. PubMed ID: 10933640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histatin-5 induces the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisae.
    da Rocha Curvelo JA; Reis de Sá LF; Moraes DC; Soares RM; Ferreira-Pereira A
    J Mycol Med; 2018 Mar; 28(1):137-142. PubMed ID: 29217144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of potassium on Saccharomyces cerevisiae resistance to fluconazole.
    Stella CA; Burgos HI
    Antimicrob Agents Chemother; 2001 May; 45(5):1589-90. PubMed ID: 11302836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitisation of drug-resistant and drug-sensitive yeast cells to antifungals.
    Cernicka J; Kozovska Z; Hnatova M; Valachovic M; Hapala I; Riedl Z; Hajós G; Subik J
    Int J Antimicrob Agents; 2007 Feb; 29(2):170-8. PubMed ID: 17204400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic AMP and fluconazole resistance in Saccharomyces cerevisiae.
    Kontoyiannis DP; Rupp S
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1743-4. PubMed ID: 10817746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.
    Billack B; Santoro M; Lau-Cam C
    Microb Drug Resist; 2009 Jun; 15(2):77-83. PubMed ID: 19432523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of gallic acid ester derivatives on Saccharomyces cerevisiae multidrug resistance protein Pdr5p.
    Pereira Rangel L; Fritzen M; Yunes RA; Leal PC; Creczynski-Pasa TB; Ferreira-Pereira A
    FEMS Yeast Res; 2010 May; 10(3):244-51. PubMed ID: 20132313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
    Linares MJ; Charriel G; Solís F; Casal M
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Sge1 protein of Saccharomyces cerevisiae is a membrane-associated multidrug transporter.
    Ehrenhofer-Murray AE; Seitz MU; Sengstag C
    Yeast; 1998 Jan; 14(1):49-65. PubMed ID: 9483795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
    Nakamura K; Niimi M; Niimi K; Holmes AR; Yates JE; Decottignies A; Monk BC; Goffeau A; Cannon RD
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3366-74. PubMed ID: 11709310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in crystal violet uptake and cation-induced death among yeast sterol mutants.
    Bard M; Lees ND; Burrows LS; Kleinhans FW
    J Bacteriol; 1978 Sep; 135(3):1146-8. PubMed ID: 357417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae.
    Salonen JH; Richardson MD; Gallacher K; Issakainen J; Helenius H; Lehtonen OP; Nikoskelainen J
    J Hosp Infect; 2000 Aug; 45(4):293-301. PubMed ID: 10973747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nystatin-rhodamine B assay for estimating activity of killer toxin from Kluyveromyces lactis.
    Palková Z; Vondrejs V
    Methods Mol Biol; 1996; 53():325-9. PubMed ID: 8924993
    [No Abstract]   [Full Text] [Related]  

  • 18. Batzelladine D and norbatzelladine L purified from marine sponge Monanchora arbuscula induce the reversal of fluconazole.
    Domingos LTS; Santos MFC; de Moraes DC; de Sá LFR; da Silva VAD; Meuren LM; Berlinck RGS; Ferreira-Pereira A
    Bioorg Chem; 2020 Dec; 105():104402. PubMed ID: 33130347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae.
    Barker KS; Pearson MM; Rogers PD
    J Antimicrob Chemother; 2003 May; 51(5):1131-40. PubMed ID: 12697649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.